Supply Chain Archives
09/10/2025
Scale Smarter: How Global Supply Chain Centers Amplify CGT Program Growth
Cell and gene therapy (CGT) programs are among the most complex and sensitive operations in the life sciences. From cryopreservation and biostorage to logistics and regulatory compliance, every step in the supply chain can influence product integrity, clinical timelines, and the scalability of the program. For program heads as well as clinical and technical operations teams, the challenge becomes bigger than merely moving materials. It quickly becomes a challenge of scaling efficiently while maintaining compliance and supporting growth across a global network.
08/25/2025
What’s Next for ATMP Regulation in EMEA
For advanced therapy developers expanding into Europe, regulatory approval is just the beginning. Even after securing authorization from the European Medicines Agency (EMA), companies often find themselves mired in a patchwork of national rules, pricing hurdles, and even access delays. In her recent appearance on the Beyond Biotech podcast by Labiotech, Alison Pritchard, Vice President of Business Development for Cryoport Systems in EMEA, pulled back the curtain on what it really takes to bring advanced therapies to patients across the region.
08/04/2025
ATMP Development in 2025: Promise, Pressure, and the Push to Scale
As the advanced therapy medicinal products (ATMP) sector reaches the midpoint of 2025, there’s no shortage of scientific momentum. Groundbreaking CRISPR-based therapies are making headlines. Patient access to cell and gene therapies is expanding beyond early adopter markets. And a maturing global regulatory environment is slowly but surely creating new opportunities for commercialization. But alongside this promise comes pressure.
08/01/2025
Built for Speed: How Cryoport Systems Delivers Without Compromise
In the life sciences, time isn’t just money, it impacts patient outcomes, regulatory compliance, and even trial integrity. When a temperature-sensitive shipment is delayed due to inventory shipper shortages or logistical bottlenecks, the impact can cascade across an entire program. Unfortunately, these scenarios aren’t theoretical. When you’re working with irreplaceable biologic materials, this kind of disruption quickly moves from inconvenient to unacceptable.
07/30/2025
Beyond Logistics: Why Clinical Trial Success Depends on a Connected Supply Chain Strategy
Contract Research Organizations (CROs) are the orchestrators of modern clinical trials. From protocol development to site management and data collection, they serve as the hidden infrastructure that brings therapies from bench to bedside. But in the increasingly global and complex research landscape, a CRO’s ability to execute doesn’t just depend on clinical expertise, it hinges on the strength of the supply chain supporting every material movement and site milestone.
07/29/2025
Helping CROs Strengthen Performance Through Smarter Supply Chain Strategy
The complexity of clinical trials only continues to rise, especially in areas like cell and gene therapy (CGT), where the stakes are higher and timelines tighter. Contract Research Organizations (CROs) are navigating this shift from the front lines, carefully managing operational timelines and supporting regulatory readiness while ensuring their sponsor clients receive high-quality, compliant outcomes across global sites.
06/13/2025
Expanding Clinical Trials Internationally in the ATMP Space
Expanding an advanced therapy clinical trial internationally is an exciting milestone but can be daunting for researchers and biotech teams. International trials involve challenges like country-specific regulations, Qualified Person (QP) release, and complex logistics. Early planning for these issues can help avoid delays and ensure progress.
04/18/2025
Transforming Patient Access to CGT: Q&A with Aruna Mor
Aruna Mor, Chief Commercial Officer at Cryoport Systems, recently delivered a powerful keynote at Advanced Therapies Congress in London, shedding light on the complexities of patient access and the critical steps needed to overcome these barriers. We sat down with her to delve deeper into some of the key themes of her keynote, exploring the intersection of science, logistics, supply chain, regulation, and collaboration that will determine the future of Cell and Gene Therapy (CGT).
04/14/2025
